## Objective: To investigate the efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. ## Method: Thirty-nine patients fulfilling dsm-iv-tr diagnostic criteria for schizophrenia and had depressive symptoms were studied in a prospective 6-week open-label design
β¦ LIBER β¦
Treatment of depressive symptoms in partially refractory schizophrenia: Efficacy of quetiapine versus haloperidol
β Scribed by R.A. Emsley; A.M. Jones
- Book ID
- 119575420
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 326 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0924-977X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Efficacy and safety of quetiapine for de
β
Kyoung-Uk Lee; Yang-Whan Jeon; Hae-Kook Lee; Tae-Youn Jun
π
Article
π
2009
π
John Wiley and Sons
π
English
β 121 KB
π 2 views
Efficacy and tolerability of quetiapine
β
Amr, Mostafa; Lakhan, Shaheen E; Sanhan, Sarila; Al-Rhaddad, Dahoud; Hassan, Mou
π
Article
π
2013
π
BioMed Central
π
English
β 303 KB
Efficacy of quetiapine compared with hal
β
S.C. Schulz
π
Article
π
2000
π
Elsevier Science
π
English
β 272 KB
Quetiapine versus olanzapine for the tre
β
Pinkhas Sirota; Irit Pannet; Ady Koren; Eleonora Tchernichovsky
π
Article
π
2006
π
John Wiley and Sons
π
English
β 124 KB
π 2 views
## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych
328 β Efficacy of the combination of ami
β
C. Mur De VΓu; F.J. Quintero GutiΓ©rrez Del Alamo; A. Ceverino DomΓnguez; J. Corr
π
Article
π
2008
π
Elsevier Science
π
English
β 59 KB
P.3.c.049 Efficacy and safety of quetiap
β
T. Jun; Y. Jeon; H. Lee; K. Lee
π
Article
π
2010
π
Elsevier Science
π
English
β 44 KB